Pascal Van Bleyenbergh

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Clofazimine use for nontuberculous mycobacterial infections: 10-year experience in Belgium.

Clofazimine use for nontuberculous mycobacterial infections: 10-year experience in Belgium.

Journal: BMC pulmonary medicine

Published: April 05, 2026

Correction to: Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safety.

Correction to: Outpatient parenteral antibiotic therapy in non-cystic fibrosis lung transplant recipients: characteristics, efficacy and safety.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: March 14, 2025

Multicenter study of the performance of NTM Elite agar for the detection of nontuberculous mycobacteria from patients with cystic fibrosis.

Multicenter study of the performance of NTM Elite agar for the detection of nontuberculous mycobacteria from patients with cystic fibrosis.

Journal: Microbiology spectrum

Published: August 28, 2024

Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant.

Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant.

Journal: Frontiers in public health

Published: May 14, 2024

Management challenges and outcomes for non-tuberculous mycobacterial pulmonary disease.

Management challenges and outcomes for non-tuberculous mycobacterial pulmonary disease.

Journal: IJTLD open

Published: March 19, 2024

Does pre-existing respiratory disease affect 3-month outcome following COVID hospitalisation across 4 waves: A prospective cohort analysis.

Does pre-existing respiratory disease affect 3-month outcome following COVID hospitalisation across 4 waves: A prospective cohort analysis.

Journal: Respiratory medicine and research

Published: January 25, 2024

COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis.

COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: September 17, 2023

Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes.

Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes.

Journal: Case reports in endocrinology

Published: August 29, 2022

Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge.

Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge.

Journal: ERJ open research

Published: January 04, 2022

Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics.

Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics.

Journal: Mycoses

Published: February 12, 2021

COVID-19 in lung transplant patients: A case series.

COVID-19 in lung transplant patients: A case series.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: May 26, 2020

An atypical case of a pulmonary mass in an immunocompromised patient.

An atypical case of a pulmonary mass in an immunocompromised patient.

Journal: Acta clinica Belgica

Published: August 20, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026